Fund Holdings — Casdin Capital, LLC

Total Portfolio Value:
$1.22B
Total Bought:
$106.35M
Total Sold:
$199.78M
Net Transaction:
-$93.43M
Notable People:
Eli D Casdin, Lawrence Jude Canzoneri, Alexandria Fisk, Angelo Crupi, Steven Michael Giordano
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
GeneDx Holdings Corp.CL A(WGS)3,507,1643,507,1640$269.56M$310.61M25.38%+$41.05M
Biolife Solutions Inc8,707,1658,707,1650$226.04M$198.87M16.25%-$27.17M
Revolution Medicines, Inc.(RVMD)3,699,2833,697,933-1,350$161.81M$130.76M10.68%-$31.05M
Standard BioTools Inc.(LAB)71,254,67776,075,636+4,820,959$124.70M$82.16M6.71%-$42.53M
Avidity Biosciences Inc2,045,0002,045,0000$59.47M$60.37M4.93%+$899.8K
Sarepta Therapeutics, Inc.(SRPT)1,073,500900,783-172,717$130.53M$57.49M4.70%-$73.04M
Illumina, Inc.(ILMN)750,000595,000-155,000$100.22M$47.21M3.86%-$53.02M
Alnylam Pharmaceuticals, Inc.(ALNY)140,000120,000-20,000$32.94M$32.40M2.65%-$541.0K
Blueprint Medicines Corp326,378326,3780$28.47M$28.89M2.36%+$421.0K
Beam Therapeutics Inc.(BEAM)1,250,0001,425,562+175,562$31.00M$27.84M2.27%-$3.16M
Relay Therapeutics, Inc.(RLAY)8,948,5749,098,574+150,000$36.87M$23.84M1.95%-$13.03M
Codexis, Inc.(CDXS)8,100,0008,100,0000$38.64M$21.79M1.78%-$16.85M
Verve Therapeutics Inc3,995,5713,995,5710$22.54M$18.26M1.49%-$4.28M
Endeavour Silver Corp.(EXK)650,000405,000-245,000$36.52M$17.53M1.43%-$18.99M
Neurogene Inc.(NGNE)1,295,3611,295,3610$29.61M$15.17M1.24%-$14.44M
Intellia Therapeutics, Inc.(NTLA)2,000,0002,000,0000$23.32M$14.22M1.16%-$9.10M
Denali Therapeutics Inc.(DNLI)990,000990,0000$20.18M$13.46M1.10%-$6.72M
Structure Therapeutics IncADS700,000700,0000$18.98M$12.12M0.99%-$6.87M
BeOne Medicines AGADS(ONC)040,000+40,000$0$10.89M0.89%+$10.89M
Guardant Health, Inc.(GH)350,000250,000-100,000$10.69M$10.65M0.87%-$42.5K
Maze Therapeutics, Inc.(MAZE)0946,357+946,357$0$10.42M0.85%+$10.42M
2seventy Bio Inc2,000,0002,000,0000$5.88M$9.88M0.81%+$4.00M
Veracyte, Inc.(VCYT)276,308276,3080$10.94M$8.19M0.67%-$2.75M
GE HealthCare Technologies Inc.(GEHC)0100,000+100,000$0$8.07M0.66%+$8.07M
Syndax Pharmaceuticals, Inc.(SNDX)475,000635,000+160,000$6.28M$7.80M0.64%+$1.52M
Agios Pharmaceuticals, Inc.(AGIO)250,000250,0000$8.21M$7.33M0.60%-$890.0K
Moderna, Inc.(MRNA)175,000225,000+50,000$7.28M$6.38M0.52%-$897.8K
Hims & Hers Health, Inc.CL A(HIMS)0200,000+200,000$0$5.91M0.48%+$5.91M
Tenaya Therapeutics, Inc.(TNYA)6,732,9716,732,9710$9.63M$3.84M0.31%-$5.79M
Verastem, Inc.(VSTM)0600,000+600,000$0$3.62M0.30%+$3.62M
Septerna, Inc.(SEPN)553,268553,2680$12.67M$3.20M0.26%-$9.47M
Solid Biosciences Inc0775,000+775,000$0$2.87M0.23%+$2.87M
Absci Corporation973,260973,2600$2.55M$2.44M0.20%-$107.1K
Teladoc Health, Inc.(TDOC)0300,000+300,000$0$2.39M0.20%+$2.39M
Century Therapeutics, Inc.(IPSC)5,190,5063,212,316-1,978,190$5.24M$1.53M0.12%-$3.71M
Dyne Therapeutics, Inc.(DYN)0100,000+100,000$0$1.05M0.09%+$1.05M
Contineum Therapeutics, Inc.CL A(CTNM)296,666148,333-148,333$4.35M$1.04M0.08%-$3.31M
Recursion Pharmaceuticals, Inc.CL A(RXRX)165,323165,3230$1.12M$874.6K0.07%-$243.0K
Pacific Biosciences of California, Inc.(PACB)1,035,859723,767-312,092$1.90M$854.0K0.07%-$1.04M
Prime Medicine, Inc.(PRME)367,175367,1750$1.07M$730.7K0.06%-$341.5K
Monte Rosa Therapeutics, Inc.(GLUE)86,01486,0140$596.9K$399.1K0.03%-$197.8K
Ginkgo Bioworks Holdings, Inc.CL A(DNA)36,49336,4930$358.4K$208.0K0.02%-$150.4K
Tango Therapeutics, Inc.(TNGX)1,188,349125,000-1,063,349$3.67M$171.3K0.01%-$3.50M
Kronos Bio Inc123,839123,8390$117.6K$102.2K0.01%-$15.5K
4d Molecular Therapeutics In1,150,0000-1,150,000$6.41M$0—-$6.41M
Fortrea Holdings Inc.(FTRE)275,0000-275,000$5.13M$0—-$5.13M
Page 1 of 1